Jounce Therapeutics, Inc. Free Cash Flow 2017-2022 | JNCE
Jounce Therapeutics, Inc. free cash flow from 2017 to 2022. Free cash flow can be defined as a measure of financial performance calculated as operating cash flow minus capital expenditures.
| Jounce Therapeutics, Inc. Annual Free Cash Flow |
| 2022 |
-29.80 |
| 2021 |
-83.87 |
| 2020 |
-27.88 |
| 2019 |
-31.11 |
| 2018 |
-64.97 |
| 2017 |
-106.10 |
| 2016 |
177.47 |
| 2015 |
-27.94 |
| 2014 |
-15.61 |
| Jounce Therapeutics, Inc. Quarterly Free Cash Flow |
| 2022-12-31 |
-29.80 |
| 2022-09-30 |
-88.81 |
| 2022-06-30 |
-57.03 |
| 2022-03-31 |
-33.27 |
| 2021-12-31 |
-83.87 |
| 2021-09-30 |
-55.54 |
| 2021-06-30 |
-58.62 |
| 2021-03-31 |
-33.71 |
| 2020-12-31 |
-27.88 |
| 2020-09-30 |
-67.18 |
| 2020-06-30 |
-45.03 |
| 2020-03-31 |
-23.60 |
| 2019-12-31 |
-31.11 |
| 2019-09-30 |
-12.52 |
| 2019-06-30 |
-45.04 |
| 2019-03-31 |
-23.29 |
| 2018-12-31 |
-64.97 |
| 2018-09-30 |
-45.30 |
| 2018-06-30 |
-26.64 |
| 2018-03-31 |
-21.35 |
| 2017-12-31 |
-106.10 |
| 2017-09-30 |
-80.51 |
| 2017-06-30 |
-53.97 |
| 2017-03-31 |
-24.52 |
| 2016-12-31 |
177.47 |
| 2016-09-30 |
190.31 |
| 2016-06-30 |
-23.91 |
| 2016-03-31 |
-11.71 |
